Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.
Amanda M AndersonLaurie G LandryAimon A AlkananiLaura L PyleSimeon I TaylorMark A AtkinsonClayton E MathewsBart O RoepAaron W MichelsMaki NakayamaPublished in: Proceedings of the National Academy of Sciences of the United States of America (2021)
Cytotoxic CD8 T lymphocytes play a central role in the tissue destruction of many autoimmune disorders. In type 1 diabetes (T1D), insulin and its precursor preproinsulin are major self-antigens targeted by T cells. We comprehensively examined preproinsulin specificity of CD8 T cells obtained from pancreatic islets of organ donors with and without T1D and identified epitopes throughout the entire preproinsulin protein and defective ribosomal products derived from preproinsulin messenger RNA. The frequency of preproinsulin-reactive T cells was significantly higher in T1D donors than nondiabetic donors and also differed by individual T1D donor, ranging from 3 to over 40%, with higher frequencies in T1D organ donors with HLA-A*02:01. Only T cells reactive to preproinsulin-related peptides isolated from T1D donors demonstrated potent autoreactivity. Reactivity to similar regions of preproinsulin was also observed in peripheral blood of a separate cohort of new-onset T1D patients. These findings have important implications for designing antigen-specific immunotherapies and identifying individuals that may benefit from such interventions.
Keyphrases
- type diabetes
- kidney transplantation
- peripheral blood
- glycemic control
- end stage renal disease
- cardiovascular disease
- endothelial cells
- insulin resistance
- ejection fraction
- multiple sclerosis
- chronic kidney disease
- dendritic cells
- metabolic syndrome
- peritoneal dialysis
- physical activity
- small molecule
- amino acid
- pluripotent stem cells
- protein protein